This training will review key clinical considerations involved in prescribing Doxy PEP and HIV pre-exposure prophylaxis (PrEP). 

By the end of this presentation learners will be able to:

• Understand the use of Doxycycline as post-exposure prophylaxis to prevent bacterial Sexually Transmitted Infections.
• Identify individuals who may benefit from HIV PrEP using the status neutral approach.
• Understand how to counsel patients about HIV PrEP, evaluate their suitability and monitor their progress while on PrEP.
• Discuss CDC’s recommended HIV PrEP regimens, including dosing, safety, efficacy, testing, initiation, follow-up assessments, and side effects.

Intended Audience

DSU health services staff

Contact